Proto3000 Formlabs BioMed Black Resin is supplied as a 1 L light-curable methacrylate photopolymer cartridge for Formlabs Low Force Stereolithography platforms operating at 405 nm. The material is validated on Form 3B and Form 3BL printers with a layer thickness of 100 µm and a resin bath temperature of 31 °C. The polymerised solid is a rigid, opaque matte black material intended for end-use medical device components that experience short-term contact with intact skin or mucosal membranes. The product is not indicated for permanent implantation, long-term mucosal tissue contact, or load-bearing arthroplasty applications. The cartridge includes an RFID data payload that addresses resin lot, remaining volume, and expiration lockout; this prevents dispensing of expired material and supports print log traceability under quality management systems. The black pigment package lowers optical transmission relative to clear formulations, so cure depth and surface hardness are more sensitive to layer-thickness drift, resin temperature fluctuation, and post-cure chamber loading. Underexposed matte black surfaces exhibit residual tack and reduced Shore D hardness even when visual appearance is acceptable.

What Biocompatibility Data Are Available for BioMed Black Resin?

The biological evaluation plan for a final device is normally structured around ISO 10993-1:2018, which classifies the contact type and duration. Manufacturer documentation places BioMed Black Resin in the short-term skin and mucosal membrane contact category. Cytotoxicity testing is referenced to ISO 10993-5:2009, and sensitisation and irritation testing to ISO 10993-10:2010. Some lot-specific packages include in vitro irritation via ISO 10993-23:2021, but this is not assumed for every cartridge lot. The material is not automatically hemocompatible, not endotoxin-tested, and not genotoxicity-tested as a standalone resin; those endpoints are triggered at device level when blood contact or protracted exposure exists. Chemical characterization under ISO 10993-18:2020 is required to identify leachable residual species from the methacrylate network, photoinitiator fragments, and wash solvent; colorants used in the black formulation must be included in the leachables screen because they are not present in BioMed Clear or BioMed Amber resins. Substantial biocompatibility data are available only for parts that have been fully washed and post-cured; raw green-state parts are not equivalent biological materials.

Unlike conventional engineering resins, biocompatibility is assessed on post-processed printed parts, not raw liquid resin. A printed part can still fail biological evaluation if post-cure is incomplete, wash solvent is not evaporated, or machine settings deviate from validated parameters. The documentation therefore applies only to parts washed in 99% isopropyl alcohol and post-cured at 60 °C for 60 min in Form Cure equipment. Final device manufacturers remain responsible for process validation and biological risk assessment under ISO 10993-1:2018, including data from the exact print orientation, post-processing line, and sterilisation method used in commercial production.

Published representative post-cure mechanical data place BioMed Black Resin among rigid unfilled photopolymers and not among engineering thermoplastics. The values below are manufacturer-published typical properties after the specified post-cure cycle; lot-specific certificates may show variation in stiffness and strength due to pigment dispersion and resin age.

The tensile strength at break of 35 MPa and tensile modulus of 1.5 GPa are sufficient for short-term static housings, clips with limited deflection, and instrument bodies that do not carry dynamic loads. The elongation at break of 20% permits only modest snap engagement; repeated high-strain flexures in living hinges or cantilever snaps should be avoided unless flexural fatigue experiments are run under ASTM D7774. The heat deflection temperature of 60 °C at 0.45 MPa limits the upper service temperature. Continuous load above 50 °C should not be applied without creep data generated under ISO 899-2:2003 or ASTM D2990. The notched Izod value of 25 J/m is lower than typical polycarbonate or ABS grades, so boss and rib design must avoid sharp corners; field observations from printed enclosures indicate crack initiation at undercuts, gate vestiges, and areas where support removal left a notch-like surface. The black pigment reduces cure depth compared with clear resins, so walls below 1 mm require exposure calibration and may need increased post-cure time to attain full hardness.

On Form 3B and Form 3BL lines, the two dominant process variables are resin temperature and wash solvent saturation. The resin is formulated for the heated tank at 31 °C; lower temperature raises viscosity and produces re-coat errors, while higher temperature accelerates premature dark polymerization in the resin tank. After printing, parts are washed in 99% isopropyl alcohol for 20 min; baths containing water or dissolved resin reduce washing efficiency and produce a tacky black surface. The black pigment makes residual solvent more difficult to detect visually, so hardness and residual IPA should be checked after drying and post-cure rather than relying on surface appearance. The Form Cure cycle is 60 °C for 60 min; stacked parts or parts with hollow cavities experience shadowing and require an additional cure step. These constraints apply because the photoinitiator concentration and pigment loading are tuned for the 100 µm layer height; changing to a different layer height outside the validated range is not supported by the manufacturer’s published data.

Comparison with BioMed Clear, BioMed Amber, and Standard Black Resin

BioMed Clear Resin is selected when transparency or translucency is a functional requirement, such as visual verification of internal fluid channels or optoelectronics. BioMed Amber Resin is a translucent amber alternative with similar biocompatibility documentation; it is not a direct substitute where the device specification requires matte black color. Standard Black Resin is a non-biocompatible prototyping and general engineering material. It is not supported for short-term patient contact and should not be used as a lower-cost substitute in medical device assemblies because its pigment and photoinitiator package have not been assessed under ISO 10993 and its sterilization behavior is not documented.

The difference between BioMed Black and BioMed Clear is not limited to optical appearance. The black pigment affects light transmission during printing, which changes required exposure energy at a given layer height. A part that prints successfully in BioMed Clear at 100 µm may show underexposed thin walls in BioMed Black if the print setting is not adjusted to account for pigment-induced attenuation. The black pigment also alters thermal absorption during post-cure; thin sections may reach cure temperature more rapidly, but thick sections can retain unreacted monomer in shaded areas. Therefore, post-cure validation for black parts should include cross-section hardness or solvent-wipe testing rather than relying only on cycle time.

Steam, Gamma, and Ethylene Oxide Cycles Are Validated on Final Device Geometry

Sterilization compatibility is device-level, not resin-level. Autoclave cycles at 121 °C for 30 min are representative for short-term contact devices printed in BioMed Black Resin, but the low heat deflection temperature of 60 °C at 0.45 MPa creates a distortion risk if components are stacked or placed under load during steam sterilization. Flash steam at 134 °C is outside the assured dimensional stability envelope unless device-specific geometry and load are validated; published data for deformation of BioMed Black at 134 °C are limited. Gamma irradiation in the range 25 kGy to 40 kGy can produce chain scission and loss of elongation; because comprehensive post-gamma tensile data for this specific black formulation are limited, dose mapping and tensile verification under ISO 527-2:2012 are required for load-bearing features. Ethylene oxide sterilization is governed by ISO 11135:2014; methacrylate networks can retain EtO and its by-products, so aeration time and residual gas limits under ISO 10993-7:2008 must be established.

Cleaning is performed in 99% isopropyl alcohol for 20 min using Form Wash or an equivalent dual-agitation washer. Solvent saturation is a known cause of sticky matte black surfaces; batch records should track the number of parts per wash bath and solvent refractive index or specific gravity. After washing, parts must be dried before cure to avoid solvent boiling and voids. Post-cure is 60 °C for 60 min in Form Cure with rotating tray if available; parts should not be stacked, and hollow sections should be oriented to allow light access. For dense black parts thicker than 10 mm, published data for through-cure uniformity are limited; manufacturers should section first articles and measure Shore D hardness at the center and near the surface.

On medical device production lines using Form 3BL printers, BioMed Black Resin is typically specified for patient-facing housings, handpiece shells, adapters, and short-term positioning fixtures. The matte black surface reduces specular reflection; if quantitative acceptance is required, specular gloss can be measured under ASTM D523-14. The black formulation reduces visible stain accumulation relative to clear materials, but inspection contrast is lower: cracks, delaminations, and support scars can be masked by the dark surface. Image-based inspection therefore requires diffuse side lighting and magnification. Dimensional checks should be conducted after full post-cure because shrinkage during polymerization and thermal cure changes feature size in a geometry-dependent manner. For mating clearances, process capability studies on the actual printed geometry are necessary; raw resin datasheet shrinkage values are not a substitute for lot-specific capability data under ISO 5725-2:2019. The cartridge traceability and print log should be retained as part of the device history record, and post-cure temperature should be recorded continuously because black parts can mask under-cure.

The material has been employed in short-term skin-contact housings for diagnostic devices, handles for reusable surgical instruments, and patient-specific positioning aids where dark matte finish supports camera-based tracking by reducing environmental reflection. It is not intended for intraoperative drilling guides, permanent implant components, or devices with prolonged mucosal contact exceeding the manufacturer’s indicated short-term exposure category. Where clinical use involves breached or abraded skin, the device manufacturer must extend the biological evaluation because intact-skin short-term data do not automatically cover open tissue contact. Published data for this specific configuration in open-tissue or blood-contact scenarios are limited.

When BioMed Black Resin Replaces Non-Biocompatible Black Resin in Short-Term Contact Components

Direct substitution of a non-biocompatible black resin with BioMed Black Resin is not a drop-in exercise. The replacement should start by comparing the full stress-strain curve from ASTM D638-14, not single-point datasheet values, because differences in yield behavior and elongation control snap-fit and boss deformation. Finite element models for snap features should include the published elongation at break of 20% and apply a safety factor because layer lines and pigment-induced cure variation reduce effective elongation in sections with high stress concentration. Existing designs containing living hinges, high-strain cantilever snaps, or impact-loaded latches fall outside the documented performance envelope unless flexural fatigue testing under ASTM D7774 and impact testing under ASTM D256-10 are performed on printed specimens in the exact orientation and post-cure condition.

For covers, shells, and retained non-load-bearing components, substitution is generally bounded by surface finish, sterilization validation, and regulatory file updates rather than static mechanical failure. Incoming material should be controlled by cartridge lot, and print records should include cartridge serial number, wash solvent batch, cure time, and post-cure inspection humidity. Ambient humidity above 60% RH can affect methacrylate surface cure; production environments should be maintained between 18 °C and 28 °C. If black resin shares a resin tank or wash bath with clear or standard resins, cross-contamination shifts optical cure depth and invalidates the biocompatibility documentation; dedicated tanks and wash baths are required for medical production runs.

The cartridge should be stored at 10 °C to 25 °C and shaken thoroughly before use because black pigment settles. Resin from partially used cartridges should be consumed within the manufacturer-specified open-cartridge stability window. The product is supplied with a safety data sheet referencing REACH Regulation (EC) No 1907/2006 and RoHS Directive 2011/65/EU; these statements describe the uncured resin as supplied, not the finished medical device after printing, washing, and sterilization. The replacement boundary condition is therefore a shift from non-medical prototyping to documented medical device manufacturing, with traceability and process controls replacing visual acceptance of the printed part.